SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022).

导出 OA

翻译打印收藏纠错

第一作者： César,Serrano

第一单位： Sarcoma Translational Research Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035, Barcelona, Spain. cserrano@vhio.net.

作者： César,Serrano ^[1] ; Rosa,Álvarez ^[2] ; Juan Antonio,Carrasco ^[3] ; Gloria,Marquina ^[4] ; Jerónimo,Martínez-García ^[5] ; Virginia,Martínez-Marín ^[6] ; María Ángeles,Sala ^[7] ; Ana,Sebio ^[8] ; Isabel,Sevilla ^[9] ; Javier,Martín-Broto ^[10]

作者单位： Sarcoma Translational Research Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, C/Natzaret, 115-117, 08035, Barcelona, Spain. cserrano@vhio.net. ^[1] Hospital General Universitario Gregorio Marañón, Madrid, Spain. ^[2] Hospital Álvaro Cunqueiro-Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain. ^[3] Hospital Universitario Clínico San Carlos, Madrid, Spain. ^[4] Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. ^[5] Hospital Universitario la Paz, Madrid, Spain. ^[6] Hospital Universitario Basurto, Bilbao, Spain. ^[7] Hospital de la Santa Creu I Sant Pau, Barcelona, Spain. ^[8] Hospitales Universitarios Regional y Virgen de la Victoria, Málaga, Spain. ^[9] Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. ^[10]

关键词 Avapritinib GIST Imatinib Ripretinib

主题词人类(Humans);胃肠道间质肿瘤(Gastrointestinal Stromal Tumors);医学肿瘤学(Medical Oncology);肉瘤(Sarcoma);多数赞同(Consensus);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases)

DOI 10.1007/s12094-023-03177-7

PMID 37129716

发布时间 2023-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交